Financial statements Valueadd Pharma (By Dr. Murpani)

Balance sheet of Valueadd Pharma (By Dr. Murpani)

Company age:
Age:
8 y. 9 m. 6 d.
Profit and loss statement Balance Profitability

Balance sheet data of VALUEADD PHARMA (BY DR. MURPANI)

Year
2018
2019
2020
2021
2022
2023
2024
Total assets 1 329 944,15 2 076 535,51 873 038,15 767 684,85 1 330 636,99 832 292,04 897 063,88
A. Fixed assets 0,00 0,00 20 461,60 85 873,34 37 560,22 2 888,26 0,00
B. Current assets 1 329 944,15 2 076 535,51 852 576,55 681 811,51 1 293 076,77 829 403,78 897 063,88
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 1 329 944,15 2 076 535,51 873 038,15 767 684,85 1 330 636,99 832 292,04 897 063,88
A. Equity 1 313 832,28 2 076 515,31 871 943,18 723 429,94 1 295 961,77 800 471,46 867 994,94
B. Liabilities and provisions for liabilities 16 111,87 20,20 1 094,97 44 254,91 34 675,22 31 820,58 29 068,94
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 16 111,87 20,20 1 094,97 44 194,54 34 607,94 31 820,58 29 068,94
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.